Surgical Site Infection Prevention in 2018 and Beyond
Sue Barnes, BSN, RN, CIC, FAPIC T here has never been greater focus on infection prevention than in today's health care system as a result of pay-for-performance programs, nonreimbursement policies, and mandatory reporting of health care-associated infections (HAIs). In part, this heightened attention has been generated by a demand from patient advocacy and consumer organizations for improved patient safety. 1 The majority of states in this country now have laws or regulations requiring public reporting of HAIs. 2 For almost a decade, the care necessitated to treat many of these infections has not been reimbursed by the Centers for Medicare & Medicaid Services. A different approach has been adopted by private insurers with pay-forperformance or value-based purchasing programs. Both types of programs are designed to incentivize safer care, either with financial rewards for meeting certain performance measures or with penalties for poor outcomes, such as HAIs.
3 At the same time, a variety of national collaborative infection prevention (IP) initiatives have been undertaken. Unfortunately, many of the proposed practice improvements in the IP initiatives are often ineffective in producing improved outcomes because they are not executed well or sustainable (eg, staff member hand hygiene compliance). 4 In addition, the pay-forperformance and value-based purchasing programs are not consistently effective. Authors from the Harvard and Stanford University Business Schools have reported that the penalties have had a negative effect by increasing the incidence of hospital up-coding, possibly unintentionally (ie, a provider bills a health insurance payer using a Current Procedural Terminology [CPT] code for a more expensive service than was performed) to collect greater reimbursement. 5 The Centers for Disease Control and Prevention's (CDC's) 2013 National HAI Progress Report does reflect significant reductions at the national level for nearly all types of HAIs. However, the report concludes with Despite progress, more action is needed at every level of public health and health care to eliminate infections that commonly threaten hospital patients. 6 There remains significant opportunity for innovative, evidence-based, sustainable strategies to reduce the risk and rate of HAIs.
EFFECT OF SURGICAL SITE INFECTIONS
Of all the HAIs in the United States, surgical site infections (SSIs) are the most common and costly, accounting for 20% of all HAIs, with an estimated annual national cost of $3 to $5 billion. 7 That estimate accounts for only those patients who survive. It is important to note that SSIs are associated with a two-to elevenfold increased risk of mortality.
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As the number and complexity of procedures in both inpatient and outpatient facilities continue to increase, the infection risk increases in parallel. From 1992 to 2012, the total number of inpatient surgeries in the United States increased by 17% to approximately 26.8 million and outpatient surgeries increased by 10% to approximately 17.3 million. 9 As an example of increasing procedural complexity, a number of surgical procedure types have integrated the use of robotic-assisted systems. Although this innovation has been introduced to improve outcomes, the procedures involve extremely complex, difficult-toclean instrumentation, which increases the risk of retained bioburden on instruments and associated surgical wound contamination risk. In some cases, robotic procedures have been reported to increase costs and complications, including infection.
10

SSI PREVENTION EFFORTS
The CDC estimates that 50% of all SSIs are preventable. 11 Surgical site infection prevention is the responsibility of both the patient and the health care providers. For the patient, smoking cessation, blood glucose control, and weight loss are important SSI prevention measures. For health care providers, there are myriad products and practices designed to help prevent SSIs. As procedures become more complex and numerous and are performed in a variety of settings, the approach to reducing SSI risk must continue to expand and evolve. Practice must keep pace with rapidly evolving products and practices designed to reduce SSI risk, and must be guided by the quality of supporting evidence.
Numerous national IP initiatives are dedicated to reducing SSI risk, including The Joint Commission Surgical Care Improvement Project (SCIP) and National Patient Safety Goals. The introduction of SCIP IP measures initially resulted in reduced surgical infection rates, but that effect has since leveled off. Furthermore, one element of SCIP is venous thromboembolism prophylaxis, which has been reported to increase the risk of postoperative infection.
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Experts have recommended that the focus should now be placed on additional evidence-based strategies that go beyond SCIP recommendations to prevent SSIs, such as optimizing antimicrobial prophylaxis dosing, preparing the colon with mechanical bowel preparation and oral antibiotics, optimizing tissue oxygenation, and using a surgical safety checklist. 13, 14 More comprehensive bundled approaches to SSI prevention are succeeding in decreasing SSI rates in many surgical procedure categories. 15, 16 Successful projects have been reported in which innovation and surgeon champions were key factors. One such project, the Comprehensive Unit-based Safety Program (CUSP) for Safe Surgery coordinated by the Agency for Healthcare Research and Quality, was a four-year national project to reduce SSIs and other complications in which more than 250 hospitals participated across the United States. Each enrolled hospital adopted CUSP, an approach created at Johns Hopkins Hospital, Baltimore, Maryland, for improving safety culture and engaging frontline clinicians in identifying and resolving defects in care delivery. Using this approach, the Johns Hopkins Hospital team reduced SSIs in colorectal procedures by 33%. 17 The following interventions were applied during the project: standardization of antiseptic skin preparation, administration of preoperative chlorhexidine showers, warming of patients in the preanesthesia area, adoption of enhanced sterile techniques for skin and fascial closure, and addressing previously unrecognized lapses in antibiotic prophylaxis.
COMPARISON OF SSI PREVENTION GUIDELINES
Certainly, in many ORs, there is ample opportunity to move closer to standardized, evidence-based practice to support reliable design of SSI prevention programs. Reliable design allows the consistent application of evidence-based medicine to improve outcomes. However, working against reliable design in SSI prevention is permissive clinical autonomy, which creates and allows wide performance margins. The variability among the four SSI prevention guidelines published in the past year reflects this variation in practice and interpretation of published evidence. The four recently published surgical infection prevention guidelines are from the CDC Healthcare Infection Control Practices Advisory Committee, the World Health Organization, the Wisconsin Public Health Department, and the American College of Surgeons and Surgical Infection Society. 11, [18] [19] [20] There is concurrence among these four evidencebased guidelines, including the following measures and conclusions. 11, [18] [19] [20] • Preoperative prevention measures and conclusions:
o Using a dual agent (ie, alcohol plus iodine or chlorhexidine) skin prep o There is no SSI reduction benefit from sealant o There is no SSI reduction benefit from adhesive incise drapes 
CONCLUSION
The recently published SSI prevention guidelines have successfully established concurrence on a small number of recommendations. 11, [18] [19] [20] There remains significant opportunity to continue moving toward consensus among professional organizations to increase standardization and reliable design of SSI prevention programs. In addition, advancing the practice of SSI prevention will necessitate looking beyond the basics, adopting innovative practices, and ensuring a collaborative team approach inclusive of a surgeon champion and the patient. The authors in this special infection prevention issue of the AORN Journal provide their expert insights and strategies in support of improving SSI prevention programs.
Editor's note: Current Procedural Terminology is a registered trademark of the American Medical Association, Chicago, IL.
